New Novartis announced that the company plans to purchase 100% of the total shares of Shijiao 100 grams held by Vitamin Pharmaceuticals, CSPC Shanghai, and Enbipu Pharmaceutical by issuing shares and paying in cash. The transaction price is determined to be 7.6 billion yuan. At the same time, the company plans to issue shares to no more than 35 specific investors to raise supporting capital, and the total amount of supporting capital raised shall not exceed 100% of the transaction price of the underlying assets to be purchased by issuing shares. The supporting funds raised in this transaction are intended to be used to pay cash consideration for this transaction, construction of the target company project, and supplementary working capital after deducting intermediary agency fees and related taxes.

Zhitongcaijing · 10/15 12:09
New Novartis announced that the company plans to purchase 100% of the total shares of Shijiao 100 grams held by Vitamin Pharmaceuticals, CSPC Shanghai, and Enbipu Pharmaceutical by issuing shares and paying in cash. The transaction price is determined to be 7.6 billion yuan. At the same time, the company plans to issue shares to no more than 35 specific investors to raise supporting capital, and the total amount of supporting capital raised shall not exceed 100% of the transaction price of the underlying assets to be purchased by issuing shares. The supporting funds raised in this transaction are intended to be used to pay cash consideration for this transaction, construction of the target company project, and supplementary working capital after deducting intermediary agency fees and related taxes.